Ulcerative Colitis Clinical Trials near St Louis, MO
15 studies for Ulcerative Colitis are recruiting at 21 sites within 50 miles of St Louis, Missouri, according to ClinicalTrials.gov data processed .
Distances are city-level approximations. See all Ulcerative Colitis trials in the US or all trials near St Louis.
Recruiting now
Ulcerative Colitis studies enrolling near St Louis
- Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
NCT03816345
- Phase 1
- Ages 18 years and older
- Sex: All
Nearest sites: Siteman Cancer Center at Christian Hospital (St Louis, MO); Siteman Cancer Center-South County (St Louis, MO)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 5 sites within 50 mi
- LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
NCT07415044
- Phase 2
- Ages 18 to 80 years
- Sex: All
Nearest sites: KAD Clinical Research (St Louis, MO); Specialists in Gastroenterology (St Louis, MO)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 2 sites within 50 mi
- A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)
NCT04844606
- Phase 3
- Ages 2 to 19 years
- Sex: All
Nearest site: Washington University School of Medicine (St Louis, MO)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- A Study Investigating Oral Ozanimod (RPC1063) in Pediatric Participants With Moderate to Severe Active Ulcerative Colitis
NCT05076175
- Phase 2/3
- Ages 2 to 17 years
- Sex: All
Nearest site: Washington University (St Louis, MO)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)
NCT06095128
- Phase 4
- Ages 18 to 65 years
- Sex: All
Nearest site: Washington University School of Medicine (St Louis, MO)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- BOOM-IBD2 Pivotal Clinical Trial
NCT06571669
- Interventional
- Ages 18 to 85 years
- Sex: All
Nearest site: Gateway GI Research (Objective Health) (St Louis, MO)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
NCT06937086
- Phase 3
- Ages 18 to 70 years
- Sex: All
Nearest site: Washington University School of Medicine (St Louis, MO)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- A Study to Evaluate the Pharmacokinetics, Safety and Efficacy of Afimkibart (RO7790121) in Children With Moderately to Severely Active Ulcerative Colitis
NCT07158242
- Phase 3
- Ages 2 to 17 years
- Sex: All
Nearest site: Washington University (St Louis, MO)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- A Master Protocol (IIBD): A Study of Multiple Drugs in Adults With Ulcerative Colitis or Crohn's Disease
NCT07483073
- Phase 2
- Ages 18 to 80 years
- Sex: All
Nearest site: KAD Clinical Research (St Louis, MO)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
NCT07697456
- Phase 2
- Ages 18 to 75 years
- Sex: All
Nearest site: Specialists In Gastroenterology /ID# 283939 (St Louis, MO)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- A Trial to Investigate PALI-2108 Versus Placebo in Participants With Moderately to Severely Active Ulcerative Colitis
NCT07845487
- Phase 2
- Ages 18 to 75 years
- Sex: All
Nearest site: Site US-006 (St Louis, MO)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting
NCT06581328
- Phase 4
- Ages 18 to 80 years
- Sex: All
Nearest sites: SSM Health Medical Group (Bridgeton, MO); St Charles Clinical Research (Weldon Spring, MO)
- Distance to nearest recruiting site
- ~15 mi (city-level)
- Recruiting sites
- 2 sites within 50 mi
- A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease
NCT07113522
- Phase 2
- Ages 18 to 80 years
- Sex: All
Nearest site: Mirador Therapeutics Selected Site (Bridgeton, MO)
- Distance to nearest recruiting site
- ~15 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
NCT07184996
- Phase 3
- Ages 16 to 80 years
- Sex: All
Nearest site: Gateway Gastroenterology - Site Number: 8400097 (Chesterfield, MO)
- Distance to nearest recruiting site
- ~21 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
NCT07185009
- Phase 3
- Ages 16 to 80 years
- Sex: All
Nearest site: Gateway Gastroenterology - Site Number: 8400097 (Chesterfield, MO)
- Distance to nearest recruiting site
- ~21 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
FAQ
Common questions
What is a clinical trial?
Is there compensation for joining an Ulcerative Colitis clinical trial?
How do I check if I'm eligible?
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.